These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 7181594
1. Influence of age and lean body mass on the relation of creatinine clearance and drug half-life. Hallynck T, Pijck J, Soep H. Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):330-2. PubMed ID: 7181594 [No Abstract] [Full Text] [Related]
2. Should clearance be normalised to body surface or to lean body mass? Hallynck TH, Soep HH, Thomis JA, Boelaert J, Daneels R, Dettli L. Br J Clin Pharmacol; 1981 May; 11(5):523-6. PubMed ID: 7272167 [No Abstract] [Full Text] [Related]
4. Pharmacokinetics in relation to age. Gladtke E. Boll Chim Farm; 1973 May; 112(5):333-41. PubMed ID: 4761111 [No Abstract] [Full Text] [Related]
5. Individualization of drug dosage in patients with renal disease. Dettli L. Med Clin North Am; 1974 Sep; 58(5):977-85. PubMed ID: 4425338 [No Abstract] [Full Text] [Related]
6. [Pharmacokinetics of drug excretion in children]. Prandota J. Pol Tyg Lek; 1974 Sep; 38(51-52):1601-4. PubMed ID: 6679084 [No Abstract] [Full Text] [Related]
7. [Current problems of age-related pharmacology (a review of the literature)]. Markova IV. Farmakol Toksikol; 1981 Sep; 44(4):494-9. PubMed ID: 7026280 [No Abstract] [Full Text] [Related]
8. [Pharmacokinetics and drug metabolism in children]. Prandota J, Pankow-Prandota L. Pediatr Pol; 1979 Jul; 54(7):781-8. PubMed ID: 394112 [No Abstract] [Full Text] [Related]
9. [Drug metabolism in the developing body]. Bojanek-Prokopczyk J. Postepy Hig Med Dosw; 1979 Jul; 33(5):503-31. PubMed ID: 398042 [No Abstract] [Full Text] [Related]
10. [Clinical pharmacokinetics and drug therapy in pediatrics]. Prandota J, Panków-Prandota L. Pediatr Pol; 1979 Jul; 54(7):773-80. PubMed ID: 394111 [No Abstract] [Full Text] [Related]
11. [Drugs and the young child (proceedings)]. Wesseling H. Ned Tijdschr Geneeskd; 1977 Oct 15; 121(42):1658-60. PubMed ID: 904723 [No Abstract] [Full Text] [Related]
12. Proceedings: Drug disposition during development. Morselli PL. Acta Pharm Suec; 1974 Dec 15; 11(6):647. PubMed ID: 1136799 [No Abstract] [Full Text] [Related]
13. [Drug therapy in the newborn and premature infant period]. Weingärtner L. Med Klin; 1969 Mar 21; 64(12):547-53. PubMed ID: 5785697 [No Abstract] [Full Text] [Related]
14. Aging and drug disposition: an update. Schmucker DL. Pharmacol Rev; 1985 Jun 21; 37(2):133-48. PubMed ID: 3901045 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function. Lanao JM, Domínguez-Gil A, Tabernero JM, De Castro S. Int J Clin Pharmacol Biopharm; 1979 Apr 21; 17(4):171-5. PubMed ID: 447438 [Abstract] [Full Text] [Related]
16. Serum creatinine and drug half-lives. Kampmann J, Hansen JM, Siersbaek-Nielsen K, Kristensen M. JAMA; 1973 Jan 08; 223(2):193. PubMed ID: 4739466 [No Abstract] [Full Text] [Related]
17. The influence of age on drug metabolism. Implications for drug dosage. Triggs EJ, Hooper WD, Dickinson RG. Med J Aust; 1973 Jan 08; 141(12-13):823-7. PubMed ID: 6390104 [No Abstract] [Full Text] [Related]
18. Paediatric pharmacological principles: an update. Part 3. Pharmacokinetics: metabolism and excretion. Kanneh A. Paediatr Nurs; 2002 Dec 08; 14(10):39-43. PubMed ID: 12520801 [No Abstract] [Full Text] [Related]
19. Birth weight and creatinine clearance in young adult twins: influence of genetic, prenatal, and maternal factors. Gielen M, Pinto-Sietsma SJ, Zeegers MP, Loos RJ, Fagard R, de Leeuw PW, Beunen G, Derom C, Vlietinck R. J Am Soc Nephrol; 2005 Aug 08; 16(8):2471-6. PubMed ID: 15944342 [Abstract] [Full Text] [Related]
20. [Evaluation of creatinine clearance in pediatric patients, excluding determination of creatininuria]. Astori L, Marino M, Donisi C. Quad Sclavo Diagn; 1980 Dec 08; 16(4):437-50. PubMed ID: 7244114 [Abstract] [Full Text] [Related] Page: [Next] [New Search]